Skip to main content
OpenTrials
Completed

NCT Number: NCT04246775

Low Anterior Resection Syndrome and Rectal Irrigation Study

Prospective study assessing treatment acceptability and the impact of rectal irrigation on patients with low anterior resection syndrome (LARS) in terms of quality of life and bowel function.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of Wales

Cardiff, CF14 4XW, United Kingdom

About this study

Aims: To assess if rectal irrigation improves patient symptoms and quality of life in patients with LARS and to see if the treatment is acceptable to patients.

Methods: This is a mixed methods evaluation study on functional outcomes in patients who have undergone anterior resection for rectal neoplasia and who have had bowel continuity restored between Jan 2009 and Jan 2014. Those patients deemed to have LARS who consent to participation in the study will be offered rectal irrigation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who have undergone anterior resection for rectal neoplasia, patients who have had restored bowel continuity
  • LARS score of >20 (defined LARS syndrome)
  • patients > 18 years of age.

Exclusion criteria

  • previous use of rectal irrigation
  • patients who are unable to give informed consent
  • patients who are not physically capable of performing the treatment in their home

Treatment and study plan

Peristeen

Device

rectal irrigation

Primary outcomes

  1. SF12

    Time frame: pre intervention and 6 months post

    quality of life

Secondary outcomes

  1. EORTC

    Time frame: pre intervention and 6 months post

    quality of life

  2. Low anterior resection score

    Time frame: pre intervention and 6 months post

    bowel function

  3. St Marks Faecal incontinence score

    Time frame: pre intervention and 6 months post

    bowel function

  4. treatment acceptability questionnaire

    Time frame: post training for treatment and 6 months post treatment

Other outcomes

  1. qualitative interviews

    Time frame: after 6 months treatment or drop out from treatment group

Sponsors and collaborators

Lead sponsor

Cardiff and Vale University Health Board

Other Gov

Collaborators

  • South East Wales Trials Unit (SEWTU)
  • Tenovus

Registry information

Acronym: LARRIS

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 29, 2020
Registry last updated
Jan 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.